RESET Trial - Part 1 (Followed by Reset Trial - Part 2) - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

Conditions

Immune System

Phase III

What is the purpose of this trial?

Brief Summary:

A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of ADX-102 1% Topical Dermal Cream in Subjects with Sjögren-Larsson Syndrome (SLS).

  • Trial with
    Aldeyra Therapeutics, Inc.
  • Start Date
    08/19/2018
  • End Date
    12/30/2020

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

Trial Image

For more information about this study, contact:

Mahin Dawood

  • Last Updated
    08/23/2018
  • Study HIC
    #2000022606